1. Home
  2. NXGL vs BFRG Comparison

NXGL vs BFRG Comparison

Compare NXGL & BFRG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo NexGel Inc

NXGL

NexGel Inc

HOLD

Current Price

$0.82

Market Cap

9.8M

Sector

Health Care

ML Signal

HOLD

Logo Bullfrog AI Holdings Inc.

BFRG

Bullfrog AI Holdings Inc.

HOLD

Current Price

$0.63

Market Cap

9.2M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
NXGL
BFRG
Founded
1997
2017
Country
United States
United States
Employees
19
N/A
Industry
Medical/Dental Instruments
Retail: Computer Software & Peripheral Equipment
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
9.8M
9.2M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
NXGL
BFRG
Price
$0.82
$0.63
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$2.00
N/A
AVG Volume (30 Days)
203.2K
237.8K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$42.29
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.70
$0.43
52 Week High
$3.25
$2.20

Technical Indicators

Market Signals
Indicator
NXGL
BFRG
Relative Strength Index (RSI) 33.55 51.61
Support Level N/A $0.43
Resistance Level $2.73 $0.68
Average True Range (ATR) 0.14 0.07
MACD -0.02 0.01
Stochastic Oscillator 19.69 52.43

Price Performance

Historical Comparison
NXGL
BFRG

About NXGL NexGel Inc

NexGel Inc manufactures high water content, electron beam cross-linked, aqueous polymer hydrogels, or gels, used for wound care, medical diagnostics, transdermal drug delivery, and cosmetics. The company specializes in custom gels by capitalizing on proprietary manufacturing technologies. The gels and consumer products are manufactured using proprietary and non-proprietary mixing, coating and cross-linking technologies.

About BFRG Bullfrog AI Holdings Inc.

Bullfrog AI Holdings Inc is a clinical-phase Biotechnology company using machine learning to advance medicine and improve human health. It uses artificial intelligence and machine learning to advance medicines for both internal and external projects. Its platform technology, named, bfLEAP, is an analytical AI/ML platform that is able to surmount the challenges of scalability and flexibility currently hindering researchers and clinicians by providing a more precise1, multi-dimensional understanding of its data.

Share on Social Networks: